These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20346909)

  • 1. The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4.
    Peng CC; Pearson JT; Rock DA; Joswig-Jones CA; Jones JP
    Arch Biochem Biophys; 2010 May; 497(1-2):68-81. PubMed ID: 20346909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetic mechanism for cytochrome P450 metabolism of type II binding compounds: evidence supporting direct reduction.
    Pearson J; Dahal UP; Rock D; Peng CC; Schenk JO; Joswig-Jones C; Jones JP
    Arch Biochem Biophys; 2011 Jul; 511(1-2):69-79. PubMed ID: 21530484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.
    Locuson CW; Hutzler JM; Tracy TS
    Drug Metab Dispos; 2007 Apr; 35(4):614-22. PubMed ID: 17251307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.
    Roberts AG; Campbell AP; Atkins WM
    Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2,3-Triazole-heme interactions in cytochrome P450: functionally competent triazole-water-heme complexes.
    Conner KP; Vennam P; Woods CM; Krzyaniak MD; Bowman MK; Atkins WM
    Biochemistry; 2012 Aug; 51(32):6441-57. PubMed ID: 22809252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450.
    Lee JY; Kang NS; Kang YK
    Biopolymers; 2012 Apr; 97(4):219-28. PubMed ID: 22113809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.
    Dahal UP; Joswig-Jones C; Jones JP
    J Med Chem; 2012 Jan; 55(1):280-90. PubMed ID: 22087535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.
    Shou M; Mei Q; Ettore MW; Dai R; Baillie TA; Rushmore TH
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):845-53. PubMed ID: 10359672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human cytochrome P4503A4 with ritonavir analogs.
    Sevrioukova IF; Poulos TL
    Arch Biochem Biophys; 2012 Apr; 520(2):108-16. PubMed ID: 22410611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study.
    Cameron MD; Wen B; Allen KE; Roberts AG; Schuman JT; Campbell AP; Kunze KL; Nelson SD
    Biochemistry; 2005 Nov; 44(43):14143-51. PubMed ID: 16245930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium.
    Davydov DR; Sineva EV; Sistla S; Davydova NY; Frank DJ; Sligar SG; Halpert JR
    Biochim Biophys Acta; 2010 Mar; 1797(3):378-90. PubMed ID: 20026040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation.
    Russell DA; Cerny MA
    Methods Enzymol; 2023; 690():341-368. PubMed ID: 37858534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions.
    Guryev OL; Gilep AA; Usanov SA; Estabrook RW
    Biochemistry; 2001 Apr; 40(16):5018-31. PubMed ID: 11305918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity.
    Kumar S; Davydov DR; Halpert JR
    Drug Metab Dispos; 2005 Aug; 33(8):1131-6. PubMed ID: 15870379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of ondansetron binding interactions with human cytochrome P450 enzymes CYP3A4 and CYP2D6.
    Lewis DF; Ito Y; Eddershaw PJ; Dickins M; Goldfarb PS
    Drug Metab Lett; 2010 Jan; 4(1):25-30. PubMed ID: 20201779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra.
    Chiba M; Jin L; Neway W; Vacca JP; Tata JR; Chapman K; Lin JH
    Drug Metab Dispos; 2001 Jan; 29(1):1-3. PubMed ID: 11124221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
    Isin EM; Guengerich FP
    J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: evidence for a mechanism involving nitroxide radicals and heme iron.
    Yin W; Mitra K; Stearns RA; Baillie TA; Kumar S
    Biochemistry; 2004 May; 43(18):5455-66. PubMed ID: 15122911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid P450 heme iron reduction by laser photoexcitation of Mycobacterium tuberculosis CYP121 and CYP51B1. Analysis of CO complexation reactions and reversibility of the P450/P420 equilibrium.
    Dunford AJ; McLean KJ; Sabri M; Seward HE; Heyes DJ; Scrutton NS; Munro AW
    J Biol Chem; 2007 Aug; 282(34):24816-24. PubMed ID: 17553785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.